ArticleDiscover polymers2026
Fabrication techniques for thin-walled silicone ocular implants using parylene-C coated 3D-printed molds.
Article in Discover polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Silicone drug delivery implants are widely used, but their fabrication often relies on non‑standardized, empirically tuned protocols that limit reproducibility and transfer across labs. Here, we present a reproducible and generalizable fabrication workflow that brings together design rules, process settings, and validation for rapid fabrication of complex thin-walled biocompatible silicone implants. We outline mold design choices, including vents and micro refill-valve/filter placement, and post‑processing to make smooth inner surfaces, and we compare molds using an applied release agent (mold‑release chemical) versus molds coated with a parylene‑C barrier. Contact angle, Fourier transform infrared spectroscopy (FT-IR), and residue analyses show that parylene‑C prevents cure inhibition and enables clean demolding. We then link spin‑coating variables to membrane thickness and use rheology to guide material selection for pattern fidelity. We also correlate the curing time with network formation and extractable content. Device-level cross-sectional analyses and cytocompatibility assays are also conducted, with the assays indicating excellent compatibility with cells. Taken together, this work provides practical, transferable practice guidance and a reference workflow that other laboratories can adopt to make consistent silicone drug delivery implants and move the field toward standardization. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s44347-026-00063-7.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.